Instem PLC Financials

Instem PLC Stock Summary

Instem PLC competes with MyHealthChecked Plc, JSC Halyk, Lloyds Banking, Impact Healthcare, and Direct Line. Intelligent Systems Corporation, through its subsidiary, CoreCard Software, Inc., provides technology solutions and processing services to the financial technology and services market in the United States and European Union. Intelligent Systems Corporation was founded in 1973 and is headquartered in Norcross, Georgia. Intelligent Systems operates under SoftwareApplication classification in the United States and is traded on NYSEMKT Exchange. It employs 570 people.

Instem PLC Key Financial Ratios

Generally speaking, Instem PLC's financial ratios allow both analysts and investors to convert raw data from Instem PLC's financial statements into concise, actionable information that can be used to evaluate the performance of Instem PLC over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Instem PLC reports annually and quarterly.

Instem Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Instem PLC's current stock value. Our valuation model uses many indicators to compare Instem PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Instem PLC competition to find correlations between indicators driving Instem PLC's intrinsic value. More Info.Instem PLC is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies reporting about  0.62  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Instem PLC is roughly  1.62 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Instem PLC by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Instem PLC's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Instem PLC's earnings, one of the primary drivers of an investment's value.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

If you are still planning to invest in Instem PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Instem PLC's history and understand the potential risks before investing.